0001209191-23-026372.txt : 20230501
0001209191-23-026372.hdr.sgml : 20230501
20230501200017
ACCESSION NUMBER: 0001209191-23-026372
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230420
FILED AS OF DATE: 20230501
DATE AS OF CHANGE: 20230501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kardes Hakan
CENTRAL INDEX KEY: 0001975023
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40295
FILM NUMBER: 23876052
MAIL ADDRESS:
STREET 1: C/O ALIGNMENT HEALTHCARE, INC.
STREET 2: 1100 W. TOWN AND COUNTRY ROAD, SUITE 160
CITY: ORANGE
STATE: CA
ZIP: 92868
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alignment Healthcare, Inc.
CENTRAL INDEX KEY: 0001832466
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 465596242
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 W. TOWN AND COUNTRY ROAD
STREET 2: SUITE 1600
CITY: ORANGE
STATE: CA
ZIP: 92868
BUSINESS PHONE: 844-310-2247
MAIL ADDRESS:
STREET 1: 1100 W. TOWN AND COUNTRY ROAD
STREET 2: SUITE 1600
CITY: ORANGE
STATE: CA
ZIP: 92868
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-04-20
0
0001832466
Alignment Healthcare, Inc.
ALHC
0001975023
Kardes Hakan
1100 W. TOWN & COUNTRY RD.
SUITE 1600
ORANGE
CA
92868
0
1
0
0
Chief Technology Officer
Common Stock
317907
D
Options (Right to Buy)
18.00
2031-03-25
Common Stock
69259
D
Options (Right to Buy)
9.06
2032-03-08
Common Stock
36496
D
Includes (i) 113,657 shares of Common Stock of Alignment Healthcare, Inc. (the "Company"); (ii) 20,566 shares of unvested restricted stock, all of which vest on July 15, 2023; (iii) 20,376 shares of unvested restricted stock, 50% of which vest on each of August 1, 2023 and August 1, 2024; (iv) 10,283 shares of unvested restricted stock, all of which vest on November 19, 2023; (v) 5,500 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company ("RSUs"), granted on March 25, 2021, 25% of which vested or will vest on each of the first four anniversaries of the grant date; (Cont.)
(Cont. from footnote 1) (vi) 66,000 RSUs granted on April 9, 2021, 25% of which vested or will vest on each of the first four anniversaries of the grant date; (vii) 49,669 RSUs granted on March 8, 2022, 25% of which vested or will vest on each of the first four anniversaries of the grant date; and (viii) 44,482 RSUs granted on September 12, 2022, 50% of which will vest on or about each of the third and fourth anniversaries of the grant date. An aggregate of 12,626 shares have been sold upon vesting of RSUs in non-discretionary sale-to-cover transactions. In each case, vesting is subject to the reporting person's continued service to the Company as of the applicable vesting date.
Options vested or will vest 25% on each of the first four anniversaries of the March 25, 2021 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
Options vested or will vest 25% on each of the first four anniversaries of the March 8, 2022 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
/s/ Richard A. Cross, as Attorney-in-Fact, for Hakan Kardes
2023-05-01
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints
each of (i) R. Thomas Freeman, (ii) Richard A. Cross and (iii) Thomas E.
Mitchell, signing SINGLY, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director or holder of 10% or more of the registered class of
securities of Alignment Healthcare, Inc. (the "Company"), Forms 3, 4 and 5 in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended, and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute any such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact,
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
* * * * *
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 24th day of April 2023.
By: /s/ Hakan Kardes
Name: Hakan Kardes